Prevalence and Global Factors Influencing Polypharmacy and its Clinical Phenotypes in Cancer Patients: A Systematic Review and Meta-Analysis

Abstract excerpt

<title>Abstract</title> <p> Background Polypharmacy (PP) is a rising morbidity among patients with a cancer diagnosis. Uncertainties remain regarding its exact burden, exact prevalence estimates, and definitional themes in this vulnerable cohort of patients. Methods Using PubMed, EMBASE, Scopus, the Cochrane Database of Systematic Reviews (CDSR), and Google Scholar, studies published between 2000 and 2025 were r...

Topics

Open a Topic to create a Post that cites this publication.

• Aged
• Carcinoma, Non-Small-Cell Lung
• ErbB Receptors
• Lung Neoplasms
• Mutation
• Pharmaceutical studies and practices
• Protein Kinase Inhibitors

Identifiers and source

Literature Corpus work

6de252aa-71b6-5f9f-ba4c-6551822cb624

DOI

10.21203/rs.3.rs-6896596/v1